Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Return on Sales (2020)

Historic Return on Sales for Design Therapeutics (DSGN) over the last 2 years, with Q3 2021 value amounting to 117.0%.

  • Design Therapeutics' Return on Sales rose 21500.0% to 117.0% in Q3 2021 from the same period last year, while for Sep 2021 it was 117.0%, marking a year-over-year change of. This contributed to the annual value of 36.86% for FY2020, which is N/A changed from last year.
  • Latest data reveals that Design Therapeutics reported Return on Sales of 117.0% as of Q3 2021, which was up 21500.0% from 117.81% recorded in Q2 2021.
  • Design Therapeutics' Return on Sales' 5-year high stood at 4.39% during Q1 2020, with a 5-year trough of 119.15% in Q3 2020.